TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16043733

Group type: EXPERIMENTAL
Intervention: Inhaled insulin (INH) before meals
Number of subjects: 145

Group type: COMPARATOR
Intervention: Rosiglitazone 4 mg twice a day
Number of subjects: 145
Study: 12439133

Group type: EXPERIMENTAL
Intervention: Test weight group (weighing infants before and after breastfeeding)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nontest weight group (no weighing before and after breastfeeding)
Number of subjects: 60
Study: 10048638

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/fluoride-containing dentifrice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 60
Study: 8615554

Group type: EXPERIMENTAL
Intervention: Caffeine (two doses) with paracetamol
Number of subjects: 629

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Caffeine with paracetamol
Number of subjects: 629
Study: 1679658

Group type: EXPERIMENTAL
Intervention: Terfenadine (H1-selective histamine antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compound 48/80 (histamine depleting agent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intradermal PAF injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline plasma histamine levels
Number of subjects: 0
Study: 7006883

Group type: EXPERIMENTAL
Intervention: Timolol 10 to 30 mg twice daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31763982

Group type: EXPERIMENTAL
Intervention: Final kissing balloon inflation (FKBI) after PCI
Number of subjects: 948

Group type: COMPARATOR
Intervention: No final kissing balloon inflation (FKBI) after PCI
Number of subjects: 948
Study: 31311922

Group type: EXPERIMENTAL
Intervention: Zwitterionic near-infrared fluorophore ZW800-1
Number of subjects: 0
Study: 28834253

Group type: EXPERIMENTAL
Intervention: 30 mg NaHED (Study I)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 30 mg NaHED with 75 g glucose (Study II)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no NaHED)
Number of subjects: 27
Study: 26284723

Group type: COMPARATOR
Intervention: 8 weeks nicotine patch treatment
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: 24 weeks nicotine patch treatment
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: 52 weeks nicotine patch treatment
Number of subjects: 525

Group type: COMPARATOR
Intervention: Extended treatment (24 weeks)
Number of subjects: 525

Group type: COMPARATOR
Intervention: Standard treatment (8 weeks)
Number of subjects: 525
Study: 23560519

Group type: EXPERIMENTAL
Intervention: Active TCPRFT
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham TCPRFT
Number of subjects: 51
Study: 22945761

Group type: EXPERIMENTAL
Intervention: Bazedoxifene (20 or 40 mg)
Number of subjects: 5244
Study: 19241364

Group type: EXPERIMENTAL
Intervention: Automatic 80 bpm intra‐aortic balloon pump (IABP) induced pulsatile CPB (Group B)
Number of subjects: 158
Study: 18201586

Group type: EXPERIMENTAL
Intervention: IV iron supplementation (1 g IV iron sucrose administered as a 100 mg dose at each of 10 consecutive HD sessions)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IV iron supplementation in a subgroup of 7 HD patients with low baseline CYP3A4 activity
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls (7 age-, sex-, and race-matched individuals)
Number of subjects: 12
Study: 15288482

Group type: EXPERIMENTAL
Intervention: Interferon alpha 2a 3MIU thrice weekly with ribavirin 800-1,000 mg/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Interferon alpha 2a 3MIU daily plus amantadine 200 mg/day with ribavirin 800-1,000 mg/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 80
Study: 11713358

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for purulent sputum (5 or 10 days)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: High dose inhaled steroid (fluticasone) for mucoid sputum (14 days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo for mucoid sputum (14 days)
Number of subjects: 63
Study: 9393423

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate rinses
Number of subjects: 595

Group type: COMPARATOR
Intervention: Control (no chlorhexidine)
Number of subjects: 595
Study: 7961584

Group type: EXPERIMENTAL
Intervention: Clozapine (mean dose 5.99 ± 2.6 mg/kg/day for 6 weeks)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Haloperidol (mean dose 0.24 ± 0.20 mg/kg/day for 6 weeks)
Number of subjects: 11
Study: 3330986

Group type: EXPERIMENTAL
Intervention: Pinacidil (64.3 mg/day for 8.5 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Hydralazine (163.3 mg/day for 8.3 weeks)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pinacidil and Hydralazine (both treatments)
Number of subjects: 29
Study: 30648879

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral treatment (CBT)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral treatment supported by the ETIOBE web platform
Number of subjects: 47
Study: 29082794

Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding after birth
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 1679
Study: 25794112

Group type: EXPERIMENTAL
Intervention: Hypothermia with xenon
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hypothermia only
Number of subjects: 32
Study: 23506344

Group type: EXPERIMENTAL
Intervention: Human fibroblast-derived dermal substitute (HFDS) plus four-layer compression therapy
Number of subjects: 366

Group type: COMPARATOR
Intervention: Compression therapy alone (Control)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 366
Study: 21199975

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavior therapy (TF-CBT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual care (child-centered therapy)
Number of subjects: 124
Study: 19934803

Group type: EXPERIMENTAL
Intervention: DC electrical stimulation
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control (no DC electrical stimulation)
Number of subjects: 107
Study: 16908310

Group type: EXPERIMENTAL
Intervention: Histidine-tryptophan-ketoglutarate (HTK) solution
Number of subjects: 102

Group type: COMPARATOR
Intervention: University of Wisconsin (UW) solution
Number of subjects: 102
Study: 15005595

Group type: EXPERIMENTAL
Intervention: Quantec Spinal Image System (QSIS) with 3 scans and 1 measurement
Number of subjects: 200

Group type: COMPARATOR
Intervention: Quantec Spinal Image System (QSIS) with 1 scan
Number of subjects: 200
Study: 11575413

Group type: EXPERIMENTAL
Intervention: Propofol (fentanyl 10-15 microg kg(‐1) and propofol 2-6 mg kg(‐1) intraoperatively and a propofol infusion for 3 h postoperatively)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Lorazepam followed by midazolam (fentanyl 10-15 microg kg(‐1) and midazolam 0.05-0.075 mg kg(‐1) intraoperatively and a midazolam infusion for 3 h postoperatively)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 78
Study: 9512847

Group type: EXPERIMENTAL
Intervention: Oesophageal Doppler monitor (ODM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Thermodilution technique
Number of subjects: 18
Study: 7527161

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (verapamil, nifedipine, verapamil+nifedipine)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride
Number of subjects: 329

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 329
Study: 2920535

Group type: EXPERIMENTAL
Intervention: 94 mg of iron per day as ferrous sulphate with multivitamins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo of multivitamins without iron
Number of subjects: 0
Study: 5575973

Group type: EXPERIMENTAL
Intervention: Silicone 300
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 30
Study: 30875743

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Eccentric Contraction Training
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control Phase
Number of subjects: 11
Study: 27999052

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 81

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 81
Study: 25719718

Group type: EXPERIMENTAL
Intervention: Gluteal augmentation with silicone implants
Number of subjects: 0
Study: 23262939

Group type: EXPERIMENTAL
Intervention: Porcine dermis
Number of subjects: 115

Group type: COMPARATOR
Intervention: Polypropylene mesh
Number of subjects: 115
Study: 21425063

Group type: EXPERIMENTAL
Intervention: Postoperative nasal packing
Number of subjects: 2

Group type: COMPARATOR
Intervention: No postoperative nasal packing
Number of subjects: 2
Study: 18842313

Group type: EXPERIMENTAL
Intervention: Single metronome synchronization (synchronized maximal flexion of the right arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double metronome within-limb synchronization (synchronized both flexion and extension of the right arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double metronome between-limb synchronization (synchronized flexion of each arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different metronome synchronization strategies
Number of subjects: 0
Study: 17268167

Group type: EXPERIMENTAL
Intervention: Post-operative monitoring for embolic signals (ES) using transcranial Doppler (TCD)
Number of subjects: 141
Study: 14727224

Group type: EXPERIMENTAL
Intervention: Smallpox vaccine
Number of subjects: 28
Study: 11516803

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5mg daily for 3 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 9494064

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg (steady state)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omeprazole 40 mg (steady state)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biological in vitro experiments with pantoprazole
Number of subjects: 0
Study: 7529921

Group type: EXPERIMENTAL
Intervention: Granulocyte growth factor
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 3056499

Group type: EXPERIMENTAL
Intervention: Closed suction wound drainage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine drainage (control)
Number of subjects: 0
Study: 30554193

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement of 4,000 IU daily for 3 years
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 29149865

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) + hyperthermic intra‐operative peritoneal chemotherapy (HIPC) with cisplatin
Number of subjects: 32
Study: 26778391

Group type: EXPERIMENTAL
Intervention: Herbal toothpaste (Sudantha®)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 80
Study: 23479153

Group type: EXPERIMENTAL
Intervention: Nutritional Intervention (NI)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Nutritional Intervention and Exercise Practice (NIE)
Number of subjects: 82
Study: 22041349

Group type: EXPERIMENTAL
Intervention: Antithrombotic agents
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6
Study: 19050988

Group type: EXPERIMENTAL
Intervention: Bedside + Booster
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Faxed Referral
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard Referral
Number of subjects: 90
Study: 16595246

Group type: EXPERIMENTAL
Intervention: Alternate day triptorelin administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily triptorelin administration
Number of subjects: 0
Study: 16424845

Group type: EXPERIMENTAL
Intervention: Insulin-enriched warm blood cardioplegia (IWBC) (10 UI/L)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Warm blood cardioplegia (Control group)
Number of subjects: 268
Study: 15190658

Group type: EXPERIMENTAL
Intervention: Size 3 LMA
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Size 4 LMA
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Size 5 LMA
Number of subjects: 135
Study: 10416302

Group type: EXPERIMENTAL
Intervention: Open laparoscopy
Number of subjects: 253

Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 253
Study: 8528638

Group type: EXPERIMENTAL
Intervention: Immunotherapy with IL‐2 and LAK cells
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard postoperative radiation therapy or chemotherapy (control group)
Number of subjects: 105
Study: 2305009

Group type: EXPERIMENTAL
Intervention: Melatonin (MLT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6775300

Group type: EXPERIMENTAL
Intervention: Nitroglycerin microcapsule preparation 2.5 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitroglycerin microcapsule preparation 7.5 mg
Number of subjects: 15
Study: 29334040

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTXA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 27693759

Group type: EXPERIMENTAL
Intervention: SHINE intervention with added case management and group outings into nature
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care with pediatrician's recommendation to visit parks and written resources (park prescription)
Number of subjects: 0
Study: 25016261

Group type: EXPERIMENTAL
Intervention: Enteral immune nutrition (EIN group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional enteral nutrition (EN group)
Number of subjects: 60
Study: 22449296

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 4752

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 4752
Study: 20370813

Group type: COMPARATOR
Intervention: Teacher-directed, classroom-based programme of physical exercise for 15 minutes, delivered approximately 30 minutes after lunch during one week.
Number of subjects: 1224

Group type: COMPARATOR
Intervention: No exercise programme during the other week (control group).
Number of subjects: 1224
Study: 18306246

Group type: EXPERIMENTAL
Intervention: Short pulse carbon dioxide laser
Number of subjects: 12

Group type: COMPARATOR
Intervention: Colorado needle with electrocautery
Number of subjects: 12
Study: 17342879

Group type: EXPERIMENTAL
Intervention: High dairy meal (500 mg Ca+2)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Low dairy meal (80 mg Ca+2)
Number of subjects: 2
Study: 12827327

Group type: EXPERIMENTAL
Intervention: SWL in situ (group 1)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: SWL after manipulation (group 2)
Number of subjects: 130
Study: 10945081

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Recreational activities and support (ATY)
Number of subjects: 34
Study: 9222387

Group type: EXPERIMENTAL
Intervention: Lysine Clonixinate (LC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 24
Study: 1595918

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (1 microgram/kg)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (2 micrograms/kg)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (4 micrograms/kg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Intravenous fentanyl (1, 2, or 4 micrograms/kg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Saline solution (epidural)
Number of subjects: 154
Study: 6362814

Group type: EXPERIMENTAL
Intervention: FAC + BCG
Number of subjects: 238

Group type: COMPARATOR
Intervention: FAC alone
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: FAC with irradiation
Number of subjects: 238

Group type: COMPARATOR
Intervention: FAC without irradiation
Number of subjects: 238
Study: 31003650

Group type: EXPERIMENTAL
Intervention: Telerehabilitation after discharge
Number of subjects: 228

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 228
Study: 30410937

Group type: EXPERIMENTAL
Intervention: Plasma A42 level in AD patients
Number of subjects: 58

Group type: COMPARATOR
Intervention: Plasma A42 level in control group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: CSF A levels in AD patients
Number of subjects: 58

Group type: COMPARATOR
Intervention: CSF A levels in control group
Number of subjects: 58
Study: 26553256

Group type: EXPERIMENTAL
Intervention: Denture adhesives
Number of subjects: 49
Study: 23756935

Group type: EXPERIMENTAL
Intervention: Supportive interface
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard interface
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Technology (both interfaces)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer collaboration
Number of subjects: 0
Study: 22466810

Group type: EXPERIMENTAL
Intervention: TAXUS paclitaxel‐eluting stent (PES)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Low levels of interleukin‐6 (IL‐6) at admission
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Low admission levels of cardiotrophin‐1 (CT‐1)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Lower values of IL‐1ra, MMP9, and MPO at 30 days
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Decline in IL‐1ra, MCP‐1, and MMP9 from admission to 30 days
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Low values of IL‐6 at 30 days
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: MPO at 30 days
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Decline of MCP‐1 between admission and 30 days
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: CT‐1
Number of subjects: 501
Study: 20706733

Group type: EXPERIMENTAL
Intervention: Single training session (STS) at 60° s(‐1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Single training session (STS) at 180° s(‐1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Single training session (STS) at both velocities
Number of subjects: 17
Study: 18590560

Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15908177

Group type: EXPERIMENTAL
Intervention: Astronauts' monocytes after 5-11 days of spaceflight
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Astronauts' monocytes after spaceflight
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (non-astronauts)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Levels of cortisol, epinephrine, and norepinephrine after spaceflight
Number of subjects: 34
Study: 12714861

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 4964

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 4964
Study: 10352397

Group type: EXPERIMENTAL
Intervention: Recombinant human GH (0.18 U/kg IBW/week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (vehicle injection)
Number of subjects: 24
Study: 8748889

Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (2 tablets daily)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (1 tablet daily)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (4 tablets daily)
Number of subjects: 104
Study: 1981017

Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg od)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Captopril (25 mg bid)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 24
Study: 6163573

Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg, two tablets)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31676201

Group type: EXPERIMENTAL
Intervention: Action planning
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dissonance‐based
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Reflection
Number of subjects: 100
Study: 31443815

Group type: EXPERIMENTAL
Intervention: Diabetes education plus stress management
Number of subjects: 121

Group type: COMPARATOR
Intervention: Diabetes education
Number of subjects: 121
Study: 29017395

Group type: EXPERIMENTAL
Intervention: EABhigh
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EABlow
Number of subjects: 15

Group type: COMPARATOR
Intervention: Classical cycling
Number of subjects: 15
Study: 26817505

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 25305053

Group type: EXPERIMENTAL
Intervention: Chimney stove
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Combined maternal/infant null GSTT1
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Expressed GST genes
Number of subjects: 132

Group type: COMPARATOR
Intervention: Open fires for cooking
Number of subjects: 132
Study: 22946606

Group type: EXPERIMENTAL
Intervention: Working Well health promotion program
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 297
Study: 20482399

Group type: EXPERIMENTAL
Intervention: Prednisone and Azathioprine (AZA)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Prednisone and Cyclosporine (CyA)
Number of subjects: 21
Study: 18361314

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 300 mg daily
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ticlopidine 2 x 250 mg daily
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both ASA and ticlopidine
Number of subjects: 28
Study: 16253799

Group type: COMPARATOR
Intervention: Standard tube feeding formula (n=14)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formula acidified using potassium sorbate to a pH of 4.25 (n=16)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 11850161

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (2 g/0.5 g/q8h)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Imipenem/cilastatin (0.5 g/0.5 g/q8h)
Number of subjects: 237
Study: 10486669

Group type: EXPERIMENTAL
Intervention: DBP < or = 80 mmHg
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: DBP < or = 85 mmHg
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: DBP < or = 90 mmHg
Number of subjects: 922
Study: 9180976

Group type: EXPERIMENTAL
Intervention: Curare (AC) group with atracurium 0.25 mg.kg‐1 for intubation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group without curare (SC)
Number of subjects: 50
Study: 1721171

Group type: EXPERIMENTAL
Intervention: Autodecremental burst pacing
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Decremental scanning
Number of subjects: 22